Literature DB >> 6124424

A comparison of the psychotropic profiles of tofisopam and diazepam.

A Bond, M Lader.   

Abstract

Twelve normal subjects were tested on a number of measures both before and 1,3 and 5 h after 10 mg diazepam, 100 and 200 mg tofisopam and a placebo. The measures included self-ratings of mood, bodily symptoms, hostility and sleep, the electroencephalogram (EEG), reaction time, tapping, digit symbol substitution, the symbol copying test, and plasma levels. Diazepam showed a clear profile of action, producing EEG changes, pronounced sedation and psychological impairment. The last two effects were maximal at 1 h and had worn off by 5 h. The EEG was recorded at 3 h only. Tofisopam in no way resembled diazepam. It produced no changes on the EEG or psychological tests and a very mild stimulant effect was apparent on the ratings. While diazepam was easily detectable in the blood, tofisopam did not bind to benzodiazepine receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124424     DOI: 10.1007/bf00542458

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Clinical and therapeutical problems of mild (non-psychotic) mental depressions.

Authors:  Z Böszörményi
Journal:  Ther Hung       Date:  1975

2.  The clinical evaluation of Grandaxin used in the treatment of outpatients (a multicentric study).

Authors:  G Várady; K Bolla; J Sebö
Journal:  Ther Hung       Date:  1975

3.  Residual effects of flunitrazepam.

Authors:  A J Bond; M H Lader
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

4.  An inventory for assessing different kinds of hostility.

Authors:  A H BUSS; A DURKEE
Journal:  J Consult Psychol       Date:  1957-08

5.  The differential effects of chlordiazepoxide and oxazepam on hostility in a small group setting.

Authors:  G E Kochansky; C salzman; R I Shader; J S Harmatz; A M Ogeltree
Journal:  Am J Psychiatry       Date:  1975-08       Impact factor: 18.112

6.  Effects of chlordiazepoxide and oxazepam administration on verbal hostility.

Authors:  G E Kochansky; C Salzman; R I Shader; J S Harmatz; A M Ogletree
Journal:  Arch Gen Psychiatry       Date:  1977-12

7.  The residual effects of flurazepam.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1973-09-28

8.  Residual effects of hypnotics.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1972

9.  Impaired performance and sedation after a single dose of lorazepam.

Authors:  S E File; A J Bond
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

10.  Tofisopam, a novel 3,4-benzodiazepine: multiple-dose effects on psychomotor skills and memory. Comparison with diazepam and interactions with ethanol.

Authors:  T Seppälä; E Palva; M J Mattila; K Korttila; R C Shrotriya
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  5 in total

1.  The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.

Authors:  A Higgitt; M Lader; P Fonagy
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The psychopharmacological effects of premazepam, diazepam and placebo in healthy human subjects.

Authors:  S Golombok; M Lader
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

3.  Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG.

Authors:  A Bond; M Lader; R Shrotriya
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  On the Physiological Modulation and Potential Mechanisms Underlying Parieto-Occipital Alpha Oscillations.

Authors:  Diego Lozano-Soldevilla
Journal:  Front Comput Neurosci       Date:  2018-04-04       Impact factor: 2.380

Review 5.  'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports.

Authors:  Laura Orsolini; John M Corkery; Stefania Chiappini; Amira Guirguis; Alessandro Vento; Domenico De Berardis; Duccio Papanti; Fabrizio Schifano
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.